Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Sunday
May 08
16:55 - 17:55
Room D2
New technologies in clinical practice
Daniela Schmitt, Germany;
Jeroen Van de Kamer, The Netherlands
2540
Proffered Papers
Physics
17:25 - 17:35
Prompt-gamma imaging for prostate cancer proton therapy: CNN-based detection of anatomical changes
Julian Pietsch, Germany
OC-0620

Abstract

Prompt-gamma imaging for prostate cancer proton therapy: CNN-based detection of anatomical changes
Authors:

Julian Pietsch1,2, Nick Piplack1,3, Jonathan Berthold1,2, Chirasak Khamfongkhruea1,4, Julia Thiele5, Tobias Hölscher5, Erik Traneus6, ‪Guillaume Janssens7, Julien Smeets7, Kristin Stützer1,2, Steffen Löck1,5,8, Christian Richter1,2,5,8

1OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; 2Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; 3Faculty of Electrical and Computer Engineering, Technische Universität Dresden, Dresden, Germany; 4Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bankok, Thailand; 5Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 6RaySearch Laboratories AB, Research, Stockholm, Sweden; 7Ion Beam Applications SA, Research, Louvain-la-Neuve, Belgium; 8German Cancer Consortium (DKTK), partner site Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany

Show Affiliations
Purpose or Objective

A clinical study (PRIMA) regarding the potential of range verification in proton therapy by prompt-gamma imaging (PGI) is carried out at our institution. As a step towards the automatic evaluation of the measured PGI data, we present an approach to detect anatomical changes in prostate cancer patients from realistically simulated PGI data using convolutional neural networks (CNNs).

Material and Methods

In-room control CTs (cCTs) were acquired in treatment position before monitoring 142 field deliveries of 10 hypo-fractioned (3Gy/fraction) prostate cancer patients with a PGI slit camera (range: 8-18 fields/patient). After manual CT registration and dose recalculation, spot-wise shifts of integrated depth-dose (IDD) profiles between cCTs and planning CTs were extracted at the 80% distal falloff position and used for ground-truth classification. Treatment fields were considered to be affected by relevant anatomical changes of the patient if >0.1% of all spots (with at least 0.1% of the total monitor units per field) had absolute IDD shifts above 5 mm. These parameters lead to a field-wise IDD ground-truth classification in optimal agreement with a prior manual field-wise classification based on dose difference maps.

Based on the cCTs, we simulated realistic PGI profiles, including Poisson noise and a positioning uncertainty of the PGI slit camera, and extracted spot-wise range shifts by comparison with the expected reference profiles for the planning CT. Spots with reliable PGI information (inside field-of-view and >5E7 protons), were considered with their Bragg peak position for generating two independent 3D spatial maps of 16x16x16 voxels (0.74x0.74x0.66 cm3): (1) The PGI-determined range shift in each voxel is the weighted average taking the spot-wise proton number into account. (2) The proton number in each voxel is summed over all respective spots and normalized per field (Fig. 1).

With these maps and the IDD classification, 3D-CNNs (6 convolutional & 2 downsampling layers) were trained using patient-wise 10-fold cross-validation on the binary task to detect anatomical changes.